Products

Equity Capital Markets

Our Equity Capital Markets team is experienced in the successful execution of all categories of private and public equity offerings

By connecting growth-oriented companies with a network of high-quality investors, we deliver compelling results for issuers of a variety of products.

  • IPO
  • Follow-on
  • SPAC IPO
  • Confidentially Marketed Public Offering (CMPO)
  • Registered Direct (RD)
  • PIPE
  • Private Placement
  • At-the-Market Offering (ATM)
  • Convertible Bond
  • Other hybrid solutions

Our relationships are based on a detailed understanding of our clients’ objectives. Our approach brings together the full capabilities of Cowen to meet their needs. Our mission is to provide a high-touch experience and be a trusted resource for all of our clients, across all stages of growth.

 

 

LEARN MORE ABOUT OUR INVESTMENT BANKING EXPERTISE

Latest Transactions

  • Agios Pharmaceuticals, Inc. is a biopharmaceutical company in the field of cellular metabolism and adjacent areas of biology, with the goal of making transformative medicines for the treatment of cancer and rare genetic diseases, or RGDs.
  • argenx SE is a clinical stage biotechnology company developing a deep pipeline of differentiated antibody based therapies for the treatment of severe autoimmune diseases and cancer.
  • Building on 30 years of experience in transfusion diagnostics, Quotient is a commercial stage diagnostics company committed to delivering solutions that reshape the way diagnostics is practiced.

Team